BENEFIT OF PROLONGED FILGOTINIB DOSING IN PATIENTS WITH ULCERATIVE COLITIS WHO DID NOT RESPOND TO INDUCTION THERAPY: DATA FROM THE SELECTION LONG-TERM EXTENSION STUDY

Severine Vermeire  1     Alessandra Oortwijn  2     Simon Hatch  3     Silvio Danese  4     Toshifumi Hibi  5     Brian Feagan  6     William J. Sandborn    
1 Department of Gastroenterology and Hepatology, University Hospitals Leuven,Leuven,Belgium
2 Galapagos NV,Leiden,Netherlands
3 Galapagos Inc.,Waltham, MA,United States
4 IBD Center, Humanitas Research Hospital,Milan,Italy
5 Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University,Tokyo,Japan
6 Robarts

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing